NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

23 hedge funds and large institutions have $1.09M invested in InVivo Therapeutics Holdings Corp in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 4 closing their positions.

Holders
23
Holders Change
+2
Holders Change %
+9.52%
% of All Funds
0.36%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
2
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$263K
2
VF
2
Virtu Financial
New York
$58K
3
Jane Street
3
Jane Street
New York
$21K
4
Two Sigma Advisers
4
Two Sigma Advisers
New York
$17K
5
Renaissance Technologies
5
Renaissance Technologies
New York
$14K

Top Sellers

1
TSS
1
Two Sigma Securities
New York
$8K
2
TRCT
2
Tower Research Capital (TRC)
New York
$0
3
SWP
3
Stratos Wealth Partners
Ohio
$0
4
SPIA
4
Steward Partners Investment Advisory
New York
$0
Name Market Value Shares Shares
Change 		Shares
Change %
TF
26
TimeScale Financial
Massachusetts
$0 2 – –
SCA
27
Snowden Capital Advisors
New York
$0 1 +1 New
Bank of America
28
Bank of America
North Carolina
$0 70 +61 +678%
1
2